ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,221Medicare Part D Prescriptions Filled, Including Refills

Rank: 359 out of 2061

$755K Total Retail Price of All Prescriptions

Rank: 289 out of 2061

479 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 479 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,894 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
NAMENDA 714 681 1 37
DONEPEZIL HCL 673 666 2 24
LEVOTHYROXINE SODIUM 409 402 3 3
LISINOPRIL 352 340 4 2
OMEPRAZOLE 251 240 5 5
SIMVASTATIN 244 228 6 1
AMLODIPINE BESYLATE 228 228 7 4
EXELON 196 180 8 94
METOPROLOL TARTRATE 195 191 9 7
WARFARIN SODIUM 191 191 10 11
HYDROCHLOROTHIAZIDE 174 174 11 12
CITALOPRAM HBR 160 153 12 20
TRAMADOL HCL 157 157 13 18
MIRTAZAPINE 155 148 14 46
TRAZODONE HCL 150 130 15 39
HYDROCODONE-ACETAMINOPHEN 143 143 S3 16 10
DIOVAN 132 132 17 41
FUROSEMIDE 132 127 17 6
BUSPIRONE HCL 130 126 19 115
GABAPENTIN 123 114 20 15
ESCITALOPRAM OXALATE 114 114 21 77
LIDODERM 113 112 22 106
ATORVASTATIN CALCIUM 105 105 23 8
GLIPIZIDE 102 102 24 55
METOPROLOL SUCCINATE 101 101 25 19
DIGOXIN 98 98 26 56
METFORMIN HCL 87 83 27 9
POTASSIUM CHLORIDE 85 81 28 16
RANITIDINE HCL 83 83 29 53
SERTRALINE HCL 83 83 29 21
AZITHROMYCIN 80 79 31 34
ARICEPT 80 80 31 322
CYMBALTA 79 78 33 59
RISPERIDONE 76 68 34 66
FLUOXETINE HCL 72 72 35 73
OXYBUTYNIN CHLORIDE ER 71 71 36 80
CARVEDILOL 70 70 37 22
QUETIAPINE FUMARATE 68 67 38 72
PAROXETINE HCL 68 68 38 61
ALPRAZOLAM 63 63 40 85
LOSARTAN POTASSIUM 63 63 40 17
LANTUS 62 62 42 48
NEXIUM 60 60 43 26
DIVALPROEX SODIUM 60 48 43 74
TAMSULOSIN HCL 60 56 43 30
LORAZEPAM 58 58 46 96
CARBIDOPA-LEVODOPA 56 56 47 97
GALANTAMINE HBR 55 43 48 272
PREDNISONE 54 54 49 32
ATENOLOL 54 54 49 13
FLUDROCORTISONE ACETATE 54 41 49 350
ENALAPRIL MALEATE 53 53 52 75
CLOPIDOGREL 53 53 52 29
SYNTHROID 53 53 52 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 41 55 87
TRIAMTERENE-HCTZ 50 50 56 38
LEXAPRO 50 50 56 211
ZOLPIDEM TARTRATE 50 38 56 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.